{
    "title": "Gilead: FDA could expand remdesivir use despite mixed data",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8652193/Gilead-remdesivir-study-finds-marginal-benefit-moderate-COVID-19-patients.html",
    "date": "2020-08-21",
    "keywords": [
        "drug",
        "remdesivir",
        "trial",
        "friday",
        "study",
        "beasley",
        "emergency",
        "use",
        "research",
        "fda",
        "course",
        "benefit",
        "gilead",
        "treatment",
        "jama",
        "editorial",
        "food",
        "administration",
        "authorization",
        "executive",
        "basis",
        "disease",
        "coronavirus",
        "recovery",
        "time",
        "company",
        "diana",
        "head",
        "companys",
        "application",
        "month",
        "approval",
        "analysis",
        "journal",
        "association",
        "improvement",
        "oxygen",
        "brainard",
        "importance",
        "question",
        "design",
        "covid19",
        "care",
        "side",
        "blood",
        "potassium",
        "efficacy",
        "duration",
        "therapy",
        "impact",
        "effect",
        "steroid",
        "exchange",
        "reporting",
        "deena",
        "tattersall",
        "sonya",
        "hepinstall",
        "diane",
        "craft"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}